Inpharmatica obtains £31.25m funding from equity investors Dresdner Kleinwort Wasserstein, Advent Venture Partners and 3i.

  • Print
  • Comment

Have your say

Mandatory Required Fields

Mandatory

Comments that are in breach or potential breach of our terms and conditions in particular clause 8, may not be published or, if published, may subsequently be taken down. In addition we may remove any comment where a complaint is made in respect of it. These actions are at our sole discretion.

  • Print
  • Comment